This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Asakura, K Articles by Rodriguez, M Search for Related Content PubMed PubMed Citation Articles by Asakura, K Articles by Rodriguez, M Social Bookmarking                   What's this?

A unique population of circulating autoantibodies promotes central nervous system remyelination

Departments of Neurology and Immunology, Mayo Clinic and Foundation, Rochester, Minnesota, USA

M Rodriguez

Departments of Neurology and Immunology, Mayo Clinic and Foundation, Rochester, Minnesota, USA

In previous studies we demonstrated that the humoral immune response directed against unique central nervous system (CNS) antigens enhanced CNS remyelination in the Theiler's virus experimental model of multiple sclerosis (MS). To expand on this observation, a mouse IgMk monoclonal antibody (mAb) which enhances CNS remyelination, was raised against normal mouse spinal cord homogenate. Characterization of this mAb revealed that it is polyreactive towards variety of intracellular antigens but also reacts to an unidentified surface antigen on oligodendrocytes. The mAb is encoded by germline immunoglobulin genes without somatic mutations consistent with the observation that it is a natural autoantibody. Recently we generated another mouse IgMk mAb raised against normal spinal cord homogenate, which also promotes CNS remyelination. Further characterization revealed that both mAbs which promote remyelination have similar binding characteristics. Conventionally Abs which recognize normal CNS components, especially oligodendrocytes or myelin, have been considered to be a disease marker or be involved in the pathogenesis of MS. However, we have identified a unique population of circulating autoantibodies which are beneficial for myelin repair. Therefore this observation indicates the need to reevaluate autoantibody production against myelin components in CSF and blood as markers of disease activity versus repair in MS.

Key Words: remyelination • immunoglobulin • Theiler's virus • natural autoantibody • multiple sclerosis

Multiple Sclerosis, Vol. 4, No. 3, 217-221 (1998)
DOI: 10.1177/135245859800400324


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Lefranc, L. Almeras, S. Dubucquoi, J. de Seze, P. Vermersch, and L. Prin Distortion of the Self-Reactive IgG Antibody Repertoire in Multiple Sclerosis as a New Diagnostic Tool J. Immunol., January 1, 2004; 172(1): 669 - 678. [Abstract] [Full Text] [PDF]

				H. DEBAT, B. AVALLE, O. CHOSE, C.-O. SARDE, A. FRIBOULET, and D. THOMAS Overpassing an aberrant V{kappa} gene to sequence an anti-idiotypic abzyme with {beta}-lactamase-like activity that could have a linkage with autoimmune diseases FASEB J, March 1, 2001; 15(3): 815 - 822. [Abstract] [Full Text] [PDF]

				K G Warren and I. Catz Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients Multiple Sclerosis, October 1, 2000; 6(5): 300 - 311. [Abstract] [PDF]